_PRIVATE_LIMITED_377552.webp)
About Dr. Cure Pharmaceuticals (India) Private Limited
Data last updated:
Dr. Cure Pharmaceuticals (India) Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 15 June 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24232KA2009PTC050124. Its GSTIN is 29AADCD1958Q1ZY (Karnataka).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹3 Lakh. It is led by directors Lajwanth Kanakaraj (Managing Director) and Kamalesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No.511 Basement Floor 67th Cross 5th Block Rajajinagar, Bangalore, Karnataka, India – 560010.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.11 Cr, a decline of 2% compared to the previous year. For the same year it recorded a net profit of ₹10.53 Lakh (net margin 2.6%) and EBITDA of ₹19.91 Lakh (EBITDA margin 4.8%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 9% over five years.
The company has about 26 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹12.77 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website drcurepharma.com.
Company details
Contact details
Dr. Cure Pharmaceuticals (India) Private Limited's registered office is in Bangalore, Karnataka. Its website is drcurepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo.511 Basement Floor 67th Cross 5th Block Rajajinagar, Bangalore, Karnataka, India – 560010
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Dr. Cure Pharmaceuticals (India) Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Dr. Cure Pharmaceuticals (India) is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Dr. Cure Pharmaceuticals (India) Private Limited, buy the company report.
Financials of Dr. Cure Pharmaceuticals (India) Private Limited
FY 2025 filings availableDr. Cure Pharmaceuticals (India) Private Limited reported revenue of ₹4.11 Cr (down 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 2% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA rose 119% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹19.91 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10.53 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.8% | ||||
| Net Profit Margin | 2.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr. Cure Pharmaceuticals (India) Private Limited, buy the company report.
Board of directors of Dr. Cure Pharmaceuticals (India) Private Limited
Dr. Cure Pharmaceuticals (India) has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lajwanth Kanakaraj | Managing Director | 15 Jun 2009 | 17 Years 4 Months | Current |
| Kamalesh Kumar | Director | 15 Jun 2009 | 17 Years 4 Months | Current |
Auditor
Dr. Cure Pharmaceuticals (India) Private Limited is audited by AGARWAL JAIN S & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AGARWAL JAIN S & CO | FY 2023 | 021929S |
Shareholding
The shareholding of Dr. Cure Pharmaceuticals (India) Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dr. Cure Pharmaceuticals (India) Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Nov 2024 | 101024599 | Canara Bank | ₹12.77 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Dr. Cure Pharmaceuticals (India) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr. Cure Pharmaceuticals (India) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Dr. Cure Pharmaceuticals (India) Private Limited has a workforce of 26 employees on its EPFO records as of Mar 29, 2024, across 1 active EPFO establishment.
GST
Dr. Cure Pharmaceuticals (India) has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCD1958Q1ZY | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dr. Cure Pharmaceuticals (India) Private Limited, buy the company report.
Recent activity
Dr. Cure Pharmaceuticals (India) Private Limited has 3 board changes on record since 2009: 2 appointments and 1 cessation. The latest: Narendrababu Byregowda ceased to be Director on 15 Sep 2021.
Frequently asked questions
Dr. Cure Pharmaceuticals (India) is an active private limited company based in Bangalore, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 15 June 2009 (17+ years old) and is registered under CIN U24232KA2009PTC050124.
Dr. Cure Pharmaceuticals (India) has 2 current directors:
- Lajwanth Kanakaraj - Managing Director
- Kamalesh Kumar - Director
The latest financial statements of Dr. Cure Pharmaceuticals (India) on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dr. Cure Pharmaceuticals (India) is 29AADCD1958Q1ZY, registered in Karnataka.
The CIN (Corporate Identification Number) of Dr. Cure Pharmaceuticals (India) is U24232KA2009PTC050124. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr. Cure Pharmaceuticals (India) was incorporated on 15 June 2009, making it 17+ years old. It is registered with the Registrar of Companies, Bangalore.
Narendrababu Byregowda ceased to be Director on 15 Sep 2021. Kamalesh Kumar was appointed as Director on 15 Jun 2009. Lajwanth Kanakaraj was appointed as Managing Director on 15 Jun 2009.
Dr. Cure Pharmaceuticals (India) can be reached through the website drcurepharma.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Dr. Cure Pharmaceuticals (India) is at No.511 Basement Floor 67th Cross 5th Block Rajajinagar, Bangalore, Karnataka, India – 560010.
Dr. Cure Pharmaceuticals (India) operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
